Allergen patch for Allergic Contact Dermatitis

Phase-Based Progress Estimates
Mayo Clinic Florida, Jacksonville, FL
Allergic Contact Dermatitis+3 More
Allergen patch - DiagnosticTest
All Sexes
What conditions do you have?

Study Summary

The purpose of this research is to assess human and artificial intelligence performance in grading contact dermatitis reactions in healthy volunteers.

Eligible Conditions

  • Allergic Contact Dermatitis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Allergic Contact Dermatitis

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 10 months

10 months
Fitzpatrick skin type assessment
6 months
AI algorithms predictions of reactions

Trial Safety

Safety Progress

1 of 3

Other trials for Allergic Contact Dermatitis

Trial Design

1 Treatment Group

Allergy Skin Patch Testing
1 of 1
Experimental Treatment

225 Total Participants · 1 Treatment Group

Primary Treatment: Allergen patch · No Placebo Group · N/A

Allergy Skin Patch TestingExperimental Group · 2 Interventions: AI-based smartphone application, Allergen patch · Intervention Types: Device, DiagnosticTest

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 10 months
Closest Location: Mayo Clinic Florida · Jacksonville, FL
Photo of Jacksonville 1Photo of Jacksonville 2Photo of Jacksonville 3
2007First Recorded Clinical Trial
1 TrialsResearching Allergic Contact Dermatitis
87 CompletedClinical Trials

Who is running the clinical trial?

Mayo ClinicLead Sponsor
2,860 Previous Clinical Trials
3,685,936 Total Patients Enrolled
Matthew Hall, MDPrincipal InvestigatorMayo Clinic

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are over the age of 18.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.